Literature DB >> 33434052

DAMPening Mortality in COVID-19: Therapeutic Insights From Basic Cardiometabolic Studies on S100A8/A9.

Nordin M J Hanssen1, Bart Spaetgens2, Prabhakara R Nagareddy3, Andrew J Murphy4.   

Abstract

Entities:  

Keywords:  COVID-19; inflammation; obesity

Mesh：

Substances：

Year:  2021        PMID： 33434052      PMCID： PMC7940571          DOI： 10.1161/CIRCULATIONAHA.120.053025

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

1.  Therapeutic Vaccine Against S100A9 (S100 Calcium-Binding Protein A9) Inhibits Thrombosis Without Increasing the Risk of Bleeding in Ischemic Stroke in Mice.

Authors:  Tomohiro Kawano; Munehisa Shimamura; Hironori Nakagami; Tatsuya Iso; Hiroshi Koriyama; Shuko Takeda; Kosuke Baba; Tsutomu Sasaki; Manabu Sakaguchi; Ryuichi Morishita; Hideki Mochizuki
Journal:  Hypertension       Date:  2018-12       Impact factor: 10.190

2.  Quinoline-3-carboxamides such as tasquinimod are not specific inhibitors of S100A9.

Authors:  Martin Pelletier; Jean-Christophe Simard; Denis Girard; Philippe A Tessier
Journal:  Blood Adv       Date:  2018-05-22

3.  Transient Intermittent Hyperglycemia Accelerates Atherosclerosis by Promoting Myelopoiesis.

Authors:  Michelle C Flynn; Michael J Kraakman; Christos Tikellis; Man K S Lee; Nordin M J Hanssen; Helene L Kammoun; Raelene J Pickering; Dragana Dragoljevic; Annas Al-Sharea; Tessa J Barrett; Fiona Hortle; Frances L Byrne; Ellen Olzomer; Domenica A McCarthy; Casper G Schalkwijk; Josephine M Forbes; Kyle Hoehn; Liza Makowski; Graeme I Lancaster; Assam El-Osta; Edward A Fisher; Ira J Goldberg; Mark E Cooper; Prabhakara R Nagareddy; Merlin C Thomas; Andrew J Murphy
Journal:  Circ Res       Date:  2020-06-22       Impact factor: 17.367

4.  Cellular softening mediates leukocyte demargination and trafficking, thereby increasing clinical blood counts.

Authors:  Meredith E Fay; David R Myers; Amit Kumar; Cory T Turbyfield; Rebecca Byler; Kaci Crawford; Robert G Mannino; Alvin Laohapant; Erika A Tyburski; Yumiko Sakurai; Michael J Rosenbluth; Neil A Switz; Todd A Sulchek; Michael D Graham; Wilbur A Lam
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

5.  Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19.

Authors:  Aymeric Silvin; Nicolas Chapuis; Garett Dunsmore; Anne-Gaëlle Goubet; Agathe Dubuisson; Lisa Derosa; Carole Almire; Clémence Hénon; Olivier Kosmider; Nathalie Droin; Philippe Rameau; Cyril Catelain; Alexia Alfaro; Charles Dussiau; Chloé Friedrich; Elise Sourdeau; Nathalie Marin; Tali-Anne Szwebel; Delphine Cantin; Luc Mouthon; Didier Borderie; Marc Deloger; Delphine Bredel; Severine Mouraud; Damien Drubay; Muriel Andrieu; Anne-Sophie Lhonneur; Véronique Saada; Annabelle Stoclin; Christophe Willekens; Fanny Pommeret; Frank Griscelli; Lai Guan Ng; Zheng Zhang; Pierre Bost; Ido Amit; Fabrice Barlesi; Aurélien Marabelle; Frédéric Pène; Bertrand Gachot; Fabrice André; Laurence Zitvogel; Florent Ginhoux; Michaela Fontenay; Eric Solary
Journal:  Cell       Date:  2020-08-05       Impact factor: 41.582
  5 in total
  5 in total

1.  Circulating levels of calprotectin, a signature of neutrophil activation in prediction of severe respiratory failure in COVID-19 patients: a multicenter, prospective study (CalCov study).

Authors:  Luis García de Guadiana-Romualdo; Carlos Rodríguez Rojas; Daniel Morell-García; David Andaluz-Ojeda; María Dolores Rodríguez Mulero; Enrique Rodríguez-Borja; Antonieta Ballesteros-Vizoso; María Dolores Calvo; Lourdes Albert-Botella; Adela Pozo Giráldez; Isabel Llompart-Alabern; Cristina Bolado Jiménez; Marta Hernández Olivo; Lucía Fernández Presa; Juan Ortega-Pérez; María José Fora Romero; Valerio Campos-Rodríguez; Andrea Ballester Férriz; Alexandra M Guiu-Martí; Leyre Pinilla Arribas; María Galindo Martínez; Edwin R Puerto-Lara; Ana Belen López Tarazaga; María Salomé Ros Braquehais; Leonor Nogales Martín; Celia Juez Santamaría; Wysalli Trapiello Fernández; Virginia Espinilla Fernández; Aleksandra Havelka; María Dolores Albaladejo-Otón
Journal:  Inflamm Res       Date:  2021-10-30       Impact factor: 6.986

2.  Platelets amplify endotheliopathy in COVID-19.

Authors:  Tessa J Barrett; MacIntosh Cornwell; Khrystyna Myndzar; Christina C Rolling; Yuhe Xia; Kamelia Drenkova; Antoine Biebuyck; Alexander T Fields; Michael Tawil; Elliot Luttrell-Williams; Eugene Yuriditsky; Grace Smith; Paolo Cotzia; Matthew D Neal; Lucy Z Kornblith; Stefania Pittaluga; Amy V Rapkiewicz; Hannah M Burgess; Ian Mohr; Kenneth A Stapleford; Deepak Voora; Kelly Ruggles; Judith Hochman; Jeffrey S Berger
Journal:  Sci Adv       Date:  2021-09-08       Impact factor: 14.136

3.  Hematopoietic progenitor cell liabilities and alarmins S100A8/A9-related inflammaging associate with frailty and predict poor cardiovascular outcomes in older adults.

Authors:  Benedetta Maria Bonora; Maria Teresa Palano; Gianluca Testa; Gian Paolo Fadini; Elena Sangalli; Fabiana Madotto; Giuseppe Persico; Francesca Casciaro; Rosa Vono; Ornella Colpani; Francesco Scavello; Roberta Cappellari; Pasquale Abete; Patrizia Orlando; Franco Carnelli; Andrea Giovanni Berardi; Stefano De Servi; Angela Raucci; Marco Giorgio; Paolo Madeddu; Gaia Spinetti
Journal:  Aging Cell       Date:  2022-02-15       Impact factor: 9.304

Review 4.  Circulating biomarkers of inflammaging as potential predictors of COVID-19 severe outcomes.

Authors:  Jacopo Sabbatinelli; Giulia Matacchione; Angelica Giuliani; Deborah Ramini; Maria Rita Rippo; Antonio Domenico Procopio; Massimiliano Bonafè; Fabiola Olivieri
Journal:  Mech Ageing Dev       Date:  2022-03-25       Impact factor: 5.498

5.  Uncovering the genetic links of SARS-CoV-2 infections on heart failure co-morbidity by a systems biology approach.

Authors:  Ge Zhang; Xiaolin Cui; Li Zhang; Gangqiong Liu; Xiaodan Zhu; Jiahong Shangguan; Wenjing Zhang; Yingying Zheng; Hui Zhang; Junnan Tang; Jinying Zhang
Journal:  ESC Heart Fail       Date:  2022-06-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.